New Anticoagulants
Top Cited Papers
Open Access
- 6 April 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (13) , 1523-1532
- https://doi.org/10.1161/circulationaha.109.853119
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee ReplacementNew England Journal of Medicine, 2009
- AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging studyJournal of Thrombosis and Haemostasis, 2009
- Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplastyThrombosis and Haemostasis, 2009
- Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapyJournal of Thrombosis and Haemostasis, 2008
- Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery DiseaseCirculation, 2008
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Extended Prophylaxis of Venous Thromboembolism with IdraparinuxNew England Journal of Medicine, 2007
- Idraparinux versus Standard Therapy for Venous Thromboembolic DiseaseNew England Journal of Medicine, 2007
- The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profileExpert Opinion on Drug Safety, 2007
- First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer TechnologyCirculation, 2006